We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHM icon
5101
Bluerock Homes Trust
BHM
$34.9M
$1.73K ﹤0.01%
99
VSTM icon
5102
Verastem
VSTM
$610M
$1.73K ﹤0.01%
581
-992
-63% -$8.18K
DOGZ icon
5103
Dogness International Corp
DOGZ
$13.4M
$1.73K ﹤0.01%
+100
New +$1.03K
RPTX
5104
DELISTED
Repare Therapeutics
RPTX
$1.71K ﹤0.01%
519
-3,457
-87% -$12.3K
BMRA icon
5105
Biomerica
BMRA
$4.98M
$1.71K ﹤0.01%
487
-89
-15% -$453
PRTC
5106
DELISTED
PureTech Health
PRTC
$1.71K ﹤0.01%
73
-64
-47% -$1.79K
CLDI icon
5107
Calidi Biotherapeutics
CLDI
$3.96M
$1.68K ﹤0.01%
4
-5
-56% -$2.56K
CISO
5108
CISO Global
CISO
$12.1M
$1.67K ﹤0.01%
2,896
-1,943
-40% -$1.84K
AMS icon
5109
American Shared Hospital Services
AMS
$9.87M
$1.67K ﹤0.01%
523
-402
-43% -$1.27K
AOGOU
5110
DELISTED
Arogo Capital Acquisition Corp. Unit
AOGOU
$1.67K ﹤0.01%
156
YYY icon
5111
Amplify CEF High Income ETF
YYY
$741M
$1.67K ﹤0.01%
139
DMRA
5112
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$1.67K ﹤0.01%
141
+122
+642% +$1.93K
RWL icon
5113
Invesco S&P 500 Revenue ETF
RWL
$9.9B
$1.67K ﹤0.01%
18
SQFT icon
5114
Presidio Property Trust
SQFT
$1.67K ﹤0.01%
239
+238
+23,800% +$2.08K
BNBX
5115
DELISTED
BNB PLUS CORP
BNBX
$1.66K ﹤0.01%
+5
New +$12.8K
CTNM
5116
Contineum Therapeutics
CTNM
$566M
$1.66K ﹤0.01%
+94
New +$1.51K
BNR
5117
Burning Rock Biotech
BNR
$92.9M
$1.64K ﹤0.01%
+261
New +$1.99K
FBIO icon
5118
Fortress Biotech
FBIO
$88.7M
$1.64K ﹤0.01%
+960
New +$1.74K
WFCF icon
5119
Where Food Comes From
WFCF
$64.7M
$1.64K ﹤0.01%
+135
New +$1.61K
EIPI
5120
FT Energy Income Partners Enhanced Income ETF
EIPI
$1.08B
$1.64K ﹤0.01%
+88
New +$1.63K
DBO icon
5121
Invesco DB Oil Fund
DBO
$366M
$1.63K ﹤0.01%
103
-85
-45% -$1.32K
DHF
5122
BNY Mellon High Yield Strategies Fund
DHF
$172M
$1.63K ﹤0.01%
+677
New +$1.61K
VRPX
5123
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$1.63K ﹤0.01%
126
+68
+117% +$3.32K
TSLY icon
5124
YieldMax TSLA Option Income Strategy ETF
TSLY
$660M
$1.62K ﹤0.01%
+20
New +$1.51K
BAYA
5125
DELISTED
Bayview Acquisition Corp
BAYA
$1.61K ﹤0.01%
157
+154
+5,133% +$1.57K

Similar funds

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.